FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3192411306> ?p ?o ?g. }

• W3192411306 abstract "You have accessJournal of UrologyProstate Cancer: Markers (MP60)1 Sep 2021MP60-16 CELL CYCLE PROGRESSION SCORE AND PTEN AS PROGNOSTIC FACTORS FOR METASTASIS IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER OVERALL, AND IN THOSE WHO RECEIVED SALVAGE RADIOTHERAPY Bruce Trock, Brent Mabey, Igor Vidal, Stephanie Glavaris, Tracy Jones, Misop Han, Alan Partin, Todd Cohen, Steven Stone, and Angelo De Marzo Bruce TrockBruce Trock More articles by this author , Brent MabeyBrent Mabey More articles by this author , Igor VidalIgor Vidal More articles by this author , Stephanie GlavarisStephanie Glavaris More articles by this author , Tracy JonesTracy Jones More articles by this author , Misop HanMisop Han More articles by this author , Alan PartinAlan Partin More articles by this author , Todd CohenTodd Cohen More articles by this author , Steven StoneSteven Stone More articles by this author , and Angelo De MarzoAngelo De Marzo More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002095.16AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: The cell cycle progression (CCP) score and PTEN have never been evaluated together for metastasis-free survival (MFS) in a prostatectomy (RP) cohort of men with intermediate and high risk (IHR) prostate cancer (PCa), nor in IHR patients who also received salvage radiation (SRT) alone or with androgen deprivation (SRT+ADT). We evaluated CCP score and PTEN in both settings. METHODS: Men received RP at Johns Hopkins from 2007-2015. Paraffin-embedded RP tissue was analyzed blind to outcome at Myriad Genetics for CCP score with qRT-PCR, and PTEN by immunohistochemistry. For overall evaluation of CCP and PTEN a case-cohort sample of IHR men was selected. Separately, a cohort of IHR men with biochemical recurrence who received SRT or SRT+ADT were also sampled to evaluate men at particularly high risk. MFS was analyzed with the proportional hazards model (weighted for case-cohort design for overall analysis), and adjusted for Cancer of the Prostate Risk Assessment Postsurgical (CAPRA-S). The cell-cycle risk (CCR) score, a fixed algorithm combining CCP and CAPRA-S was also analyzed in both contexts. Data were analyzed independently by Johns Hopkins and Myriad Genetics. RESULTS: The case-cohort included 209 men: 47% with Gleason score >4+3, 48% extra-prostatic extension, and 18% with seminal vesicle or lymph node involvement; 42 (20%) developed metastasis. In multivariable analysis, CCP and CAPRA-S were statistically significant, but not PTEN (Table section A). CCR was also strongly prognostic: HR=7.9 (95% CI 4.4, 14.5) per unit, p<0.00001. SRT (56%) or SRT+ADT (44%) were received by 172 IHR men, of whom 78% had Gleason >4+3, 48% extra-prostatic extension, and 34% seminal vesicle or lymph node involvement; 19 (11%) developed metastases. Again, CCP and CAPRA-S, but not PTEN, were statistically significant for MFS (Table section B). CCR was also statistically significant: HR=1.7 (95% CI 1.2, 2.4), p=0.002. CONCLUSIONS: This is the first comparison, in a recent cohort of IHR men, of CCP and PTEN as risk factors for metastasis, and first evaluation in IHR men receiving SRT. In both settings, CCP, but not PTEN, was significantly associated with MFS, adjusted for CAPRA-S. CCR, a fixed algorithm combining CCP and CAPRA-S was also significant in both settings. Source of Funding: Myriad Genetics, Inc., and NIH 5P50CA058236-17 Johns Hopkins Specialized Program of Research Excellence (SPORE) in Prostate Cancer © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e1048-e1048 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Bruce Trock More articles by this author Brent Mabey More articles by this author Igor Vidal More articles by this author Stephanie Glavaris More articles by this author Tracy Jones More articles by this author Misop Han More articles by this author Alan Partin More articles by this author Todd Cohen More articles by this author Steven Stone More articles by this author Angelo De Marzo More articles by this author Expand All Advertisement Loading ..." @default.
• W3192411306 created "2021-08-16" @default.
• W3192411306 creator A5000152049 @default.
• W3192411306 creator A5001703453 @default.
• W3192411306 creator A5008793371 @default.
• W3192411306 creator A5010930816 @default.
• W3192411306 creator A5030178630 @default.
• W3192411306 creator A5063449536 @default.
• W3192411306 creator A5079957777 @default.
• W3192411306 creator A5081780879 @default.
• W3192411306 creator A5088051500 @default.
• W3192411306 creator A5088387716 @default.
• W3192411306 date "2021-09-01" @default.
• W3192411306 modified "2023-09-27" @default.
• W3192411306 title "MP60-16 CELL CYCLE PROGRESSION SCORE AND PTEN AS PROGNOSTIC FACTORS FOR METASTASIS IN INTERMEDIATE AND HIGH RISK PROSTATE CANCER OVERALL, AND IN THOSE WHO RECEIVED SALVAGE RADIOTHERAPY" @default.
• W3192411306 doi "https://doi.org/10.1097/ju.0000000000002095.16" @default.
• W3192411306 hasPublicationYear "2021" @default.
• W3192411306 type Work @default.
• W3192411306 sameAs 3192411306 @default.
• W3192411306 citedByCount "0" @default.
• W3192411306 crossrefType "journal-article" @default.
• W3192411306 hasAuthorship W3192411306A5000152049 @default.
• W3192411306 hasAuthorship W3192411306A5001703453 @default.
• W3192411306 hasAuthorship W3192411306A5008793371 @default.
• W3192411306 hasAuthorship W3192411306A5010930816 @default.
• W3192411306 hasAuthorship W3192411306A5030178630 @default.
• W3192411306 hasAuthorship W3192411306A5063449536 @default.
• W3192411306 hasAuthorship W3192411306A5079957777 @default.
• W3192411306 hasAuthorship W3192411306A5081780879 @default.
• W3192411306 hasAuthorship W3192411306A5088051500 @default.
• W3192411306 hasAuthorship W3192411306A5088387716 @default.
• W3192411306 hasBestOaLocation W31924113061 @default.
• W3192411306 hasConcept C121608353 @default.
• W3192411306 hasConcept C126322002 @default.
• W3192411306 hasConcept C143998085 @default.
• W3192411306 hasConcept C185592680 @default.
• W3192411306 hasConcept C190283241 @default.
• W3192411306 hasConcept C2777609662 @default.
• W3192411306 hasConcept C2777899217 @default.
• W3192411306 hasConcept C2779013556 @default.
• W3192411306 hasConcept C2779466945 @default.
• W3192411306 hasConcept C2780192828 @default.
• W3192411306 hasConcept C509974204 @default.
• W3192411306 hasConcept C55493867 @default.
• W3192411306 hasConcept C71924100 @default.
• W3192411306 hasConcept C86554907 @default.
• W3192411306 hasConceptScore W3192411306C121608353 @default.
• W3192411306 hasConceptScore W3192411306C126322002 @default.
• W3192411306 hasConceptScore W3192411306C143998085 @default.
• W3192411306 hasConceptScore W3192411306C185592680 @default.
• W3192411306 hasConceptScore W3192411306C190283241 @default.
• W3192411306 hasConceptScore W3192411306C2777609662 @default.
• W3192411306 hasConceptScore W3192411306C2777899217 @default.
• W3192411306 hasConceptScore W3192411306C2779013556 @default.
• W3192411306 hasConceptScore W3192411306C2779466945 @default.
• W3192411306 hasConceptScore W3192411306C2780192828 @default.
• W3192411306 hasConceptScore W3192411306C509974204 @default.
• W3192411306 hasConceptScore W3192411306C55493867 @default.
• W3192411306 hasConceptScore W3192411306C71924100 @default.
• W3192411306 hasConceptScore W3192411306C86554907 @default.
• W3192411306 hasIssue "Supplement 3" @default.
• W3192411306 hasLocation W31924113061 @default.
• W3192411306 hasOpenAccess W3192411306 @default.
• W3192411306 hasPrimaryLocation W31924113061 @default.
• W3192411306 hasRelatedWork W2090160225 @default.
• W3192411306 hasRelatedWork W2117050434 @default.
• W3192411306 hasRelatedWork W2524254168 @default.
• W3192411306 hasRelatedWork W2545489389 @default.
• W3192411306 hasRelatedWork W2972701944 @default.
• W3192411306 hasRelatedWork W2981309839 @default.
• W3192411306 hasRelatedWork W3193061229 @default.
• W3192411306 hasRelatedWork W3197039060 @default.
• W3192411306 hasRelatedWork W4321996656 @default.
• W3192411306 hasRelatedWork W193188344 @default.
• W3192411306 hasVolume "206" @default.
• W3192411306 isParatext "false" @default.
• W3192411306 isRetracted "false" @default.
• W3192411306 magId "3192411306" @default.
• W3192411306 workType "article" @default.